Shire Pharmaceuticals Acquires Ferrokin BioSciences for $325,000,000

  • Feed Type
  • Date
    3/15/2012
  • Company Name
    Ferrokin BioSciences
  • Mailing Address
    2729 Debbie Court San Carlos, CA 94070
  • Company Description
    FerroKin BioSciences is a clinical stage biotechnology company based in the San Francisco Bay Area and focused on developing chelation therapies for a broad range of clinical indications.
  • Website
    http://www.ferrokin.com
  • Transaction Type
    M&A
  • Transaction Amount
    $325,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Shire has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100 million, payable in cash at closing, plus potential post-closing milestone payments of up to $225 million, depending upon the achievement of certain clinical development, regulatory and net sales targets.